| Filed On | Filing |
|---|---|
| 09 Mar 2026 |
8-K/A: Financial Statements and Exhibits
On January 6, 2026, or the Closing Date, Day One Biopharmaceuticals, Inc., or the Company or Day One, completed the acquisition, or Acquisition, of Mersana Therapeutics, Inc., or Mersana. The following unaudited pro forma condensed combi... |
Loading...
